209 related articles for article (PubMed ID: 32236673)
1. Uterine Fibroid Embolization (UFE) with Optisphere: A Prospective Study of a New, Spherical, Resorbable Embolic Agent.
Hacking N; Maclean D; Vigneswaran G; Bryant T; Modi S
Cardiovasc Intervent Radiol; 2020 Jun; 43(6):897-903. PubMed ID: 32236673
[TBL] [Abstract][Full Text] [Related]
2. A retrospective cohort study comparing a novel, spherical, resorbable particle against five established embolic agents for uterine fibroid embolisation.
Maclean D; Vigneswaran G; Bryant T; Modi S; Hacking N
Clin Radiol; 2021 Jun; 76(6):452-457. PubMed ID: 33637311
[TBL] [Abstract][Full Text] [Related]
3. Uterine fibroid embolization with acrylamido polyvinyl microspheres: prospective 12-month clinical and MRI follow-up study.
Duvnjak S; Ravn P; Green A; Andersen PE
Acta Radiol; 2017 Aug; 58(8):952-958. PubMed ID: 27872351
[TBL] [Abstract][Full Text] [Related]
4. The impact on Anti-Mullerian Hormone (AMH), uterine fibroid size and uterine artery patency following Uterine Fibroid Embolization (UFE) with a resorbable embolic agent.
Hacking N; Vigneswaran G; Maclean D; Bryant T; Umranikar S; Cheong Y; Modi S
Hum Fertil (Camb); 2022 Dec; 25(5):881-887. PubMed ID: 33926340
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Changes in Sexual Function Related to Uterine Fibroid Embolization (UFE): Results of the EFUZEN Study.
Kovacsik HV; Herbreteau D; Bommart S; Beregi JP; Bartoli JM; Sapoval M;
Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1169-1175. PubMed ID: 28321542
[TBL] [Abstract][Full Text] [Related]
6. The effect of uterine fibroid embolization on lower urinary tract symptoms.
Shveiky D; Iglesia CB; Antosh DD; Kudish BI; Peterson J; Huang CC; Spies JB
Int Urogynecol J; 2013 Aug; 24(8):1341-5. PubMed ID: 23247276
[TBL] [Abstract][Full Text] [Related]
7. One year symptom severity and health-related quality of life changes among Black African patients undergoing uterine fibroid embolisation.
Mariara C; Obura T; Hacking N; Stones W
BMC Res Notes; 2017 Jul; 10(1):240. PubMed ID: 28676073
[TBL] [Abstract][Full Text] [Related]
8. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research.
Coyne KS; Margolis MK; Murphy J; Spies J
Value Health; 2012; 15(5):674-9. PubMed ID: 22867776
[TBL] [Abstract][Full Text] [Related]
9. MRI assessment of uterine artery patency and fibroid infarction rates 6 months after uterine artery embolization with nonspherical polyvinyl alcohol.
Das R; Gonsalves M; Vlahos I; Manyonda I; Belli AM
Cardiovasc Intervent Radiol; 2013 Oct; 36(5):1280-7. PubMed ID: 23385663
[TBL] [Abstract][Full Text] [Related]
10. Randomised Controlled Trial of Particles Used in Uterine fibRoid Embolisation (PURE): Non-Spherical Polyvinyl Alcohol Versus Calibrated Microspheres.
Das R; Wale A; Renani SA; Ratnam L; Mailli L; Chun JY; Das S; Duggal B; Manyonda I; Belli AM
Cardiovasc Intervent Radiol; 2022 Feb; 45(2):207-215. PubMed ID: 34984488
[TBL] [Abstract][Full Text] [Related]
11. Pelvic Blood Flow Predicts Fibroid Volume and Embolic Required for Uterine Fibroid Embolization: A Pilot Study With 4D Flow MR Angiography.
Malone CD; Banerjee A; Alley MT; Vasanawala SS; Roberts AC; Hsiao A
AJR Am J Roentgenol; 2018 Jan; 210(1):189-200. PubMed ID: 29090998
[TBL] [Abstract][Full Text] [Related]
12. Initial experience of uterine fibroid embolization using porous gelatin sponge particles.
Katsumori T; Kasahara T; Oda M; Kotani T
Cardiovasc Intervent Radiol; 2011 Jun; 34(3):513-21. PubMed ID: 20574795
[TBL] [Abstract][Full Text] [Related]
13. [Uterine fibroid embolization with spheric micro-particles using flow guiding: safety, technical success and clinical results].
Richter GM; Radeleff B; Rimbach S; Kauffmann GW
Rofo; 2004 Nov; 176(11):1648-57. PubMed ID: 15497084
[TBL] [Abstract][Full Text] [Related]
14. Radiation Exposure During Uterine Fibroid Embolization (UFE): A Confounder-Controlled Comparison Between a State-of-the-Art Angiography Unit and a Conventional Angiography unit.
Sommer CM; Voigt W; Klapp Oliger M; Schlett CL; Erpenbach S; Thomas K; Hatopp A; Kurz P; Richter GM
Rofo; 2018 Mar; 190(3):250-258. PubMed ID: 28934806
[TBL] [Abstract][Full Text] [Related]
15. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL).
Harding G; Coyne KS; Thompson CL; Spies JB
Health Qual Life Outcomes; 2008 Nov; 6():99. PubMed ID: 19014505
[TBL] [Abstract][Full Text] [Related]
16. Comparison of outcomes and cost-effectiveness of trisacryl gelatin microspheres alone versus combined trisacryl gelatin microspheres and gelatin sponge embolization in uterine fibroid embolization.
Farrell TP; Garvey C; Adams NC; Mulholland D; Ryan JM; Guiney M; McEniff N
Acta Radiol; 2020 Sep; 61(9):1287-1296. PubMed ID: 31955609
[TBL] [Abstract][Full Text] [Related]
17. Improvement in parameters of quality of life and uterine volume reduction after uterine fibroid embolization.
Silva NACD; Szejnfeld D; Klajner RK; Mata MVMD; Aun R; Belczak SQ
Einstein (Sao Paulo); 2020; 18():eAO5458. PubMed ID: 32965299
[TBL] [Abstract][Full Text] [Related]
18. Initial results from uterine fibroid embolization for symptomatic leiomyomata.
Spies JB; Scialli AR; Jha RC; Imaoka I; Ascher SM; Fraga VM; Barth KH
J Vasc Interv Radiol; 1999 Oct; 10(9):1149-57. PubMed ID: 10527190
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical and MR imaging outcomes after uterine fibroid embolization with Bead Block and Embosphere.
Liaw JV; Yun CH; Walker TG; Kalva SP; Janne d'Othée B
Eur J Radiol; 2012 Jun; 81(6):1371-5. PubMed ID: 21439744
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted imaging properties of uterine fibroids pre- and post-uterine fibroid embolisation.
Kirpalani A; Chong J; Yang N; Jenkins SJ; Nisenbaum R; Prabhudesai V; Anthwal S; Colak E
Eur J Radiol; 2014 Sep; 83(9):1620-5. PubMed ID: 24976500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
